METLIFE INC·4

Mar 12, 4:07 PM ET

Johnson Jeh C. 4

4 · METLIFE INC · Filed Mar 12, 2026

Research Summary

AI-generated summary of this filing

Updated

MetLife (MET) Director Jeh C. Johnson Receives 65 Shares

What Happened Jeh C. Johnson, a director of MetLife, received 65 shares of MetLife common stock on 2026-03-10 at an imputed price of $70.60 per share, for a total value of $4,589. The filing lists this as an acquisition/award (code A) and reflects an imputed reinvestment of dividends into deferred shares under MetLife’s Deferred Compensation Plan for Non-Management Directors.

Key Details

  • Transaction date and price: 2026-03-10 at $70.60 per share.
  • Shares acquired: 65; transaction value: $4,589.
  • Filing date: 2026-03-12 (two days after the transaction).
  • Shares owned after the transaction: not disclosed in the Form 4.
  • Footnote: F1 — these are deferred shares created by reinvested dividends; the director deferred receipt of payable shares under the deferred compensation plan.
  • Transaction code: A (award/acquisition). No 10b5-1 plan, option exercise, sale, or gift was reported.

Context This transaction reflects routine compensation and dividend reinvestment common for non-management directors rather than an open-market purchase. While acquisitions can be interpreted positively, these deferred-share awards are standard plan mechanics and do not necessarily signal a change in the director’s view of the company.

Insider Transaction Report

Form 4
Period: 2026-03-10
Transactions
  • Award

    Common Stock

    [F1]
    2026-03-10$70.60/sh+65$4,5898,129 total
Footnotes (1)
  • [F1]Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.
Signature
/s/ Taylor McInerney Jansen, Attorney-in-fact|2026-03-12

Documents

1 file
  • 4
    wk-form4_1773346069.xmlPrimary

    FORM 4